Antimicrobial resistance (AMR) is a growing public health crisis, with nearly 1 million deaths in 2019 and projections of 10 million annually by 2050. Two major AMR pathogens, Staphylococcus aureus and Pseudomonas aeruginosa, form persistent infections often associated with biofilms and medical devices. Phage therapy—using viruses that infect and kill bacteria—offers a promising alternative to antibiotics. However, its clinical use remains limited due to gaps in our understanding of how phages infect bacterial cells.
The PHAGE project aims to elucidate the mechanisms by which two phages, phi812 (S. aureus) and phiKZ (P. aeruginosa), bind to bacterial surfaces and eject their genomes. These phages have long, contractile tails, which undergo major structural changes during infection. The project combines structural biology with advanced imaging to study these processes at high resolution and in real time.
First, I will use cryo-electron microscopy to determine the structure of the phiKZ tail in its native and contracted states. This will reveal how receptor binding triggers tail contraction and genome delivery. Second, I will visualise and quantify genome ejection in vivo using cryo-STEM and holotomography. These techniques will allow, for the first time, the direct observation of single-phage infection events on bacterial cells.
PHAGE will advance fundamental knowledge of phage biology and provide insights essential for the rational design of phage therapies. The findings will support the EU’s One Health Action Plan against AMR and contribute to developing novel treatments for drug-resistant infections.